Digital Generative AI and its impact on speed to market for pharmace... Generative AI (GenAI) is revolutionising the life sciences, and we’re just scratching the surface.
Oncology Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treat... At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated cancers, including key insights on Tibsovo & Voranigo, and the implications for patients.
